Pharmaceutical Product Development Inc PPDI Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update

Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 23 pages

Summary Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll, and durieva. ...

Industries: Drug Discovery and Development | Countries: United States, Ireland, India

Hyperphosphatemia - Pipeline Review, H2 2014

Hyperphosphatemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 77 pages

Hyperphosphatemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hyperphosphatemia - Pipeline Review, H2 2014', provides an overview of the Hyperphosphatemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperphosphatemia, complete ...

Industries: Drug Discovery and Development | Countries: World, United States

Restenosis - Pipeline Review, H2 2014

Restenosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 58 pages

Restenosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Restenosis - Pipeline Review, H2 2014', provides an overview of the Restenosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis ...

Industries: Drug Discovery and Development | Countries: World, United States

Myotonic Dystrophy - Pipeline Review, H2 2014

Myotonic Dystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 59 pages

Myotonic Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Myotonic Dystrophy - Pipeline Review, H2 2014', provides an overview of the Myotonic Dystrophy's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, ...

Industries: Drug Discovery and Development | Countries: World, United States

Seizures - Pipeline Review, H2 2014

Seizures - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 80 pages

Seizures - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Seizures - Pipeline Review, H2 2014', provides an overview of the Seizures's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seizures, complete with comparative analysis at ...

Industries: Drug Discovery and Development | Countries: World, United States

HIV-1 Infection Global Clinical Trials Review, H2, 2014

HIV-1 Infection Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • November 2014
  • 164 pages

HIV-1 Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

Chlamydia Infections Global Clinical Trials Review, H2, 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • November 2014
  • 67 pages

Chlamydia Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia Infections clinical trial scenario. This report provides elemental information and data relating to ...

Industries: Drug Discovery and Development | Countries: World, United States

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Avastra Sleep Centres Limited (Avastra) is a publicly held Australia based company that operates diagnostic sleep centers. It is one of the largest networks of sleep specialists in the US. The company operates under three business segments namely Comprehensive Care, Sleep Diagnostics, and Clinical ...

Industries: Drug Discovery and Development | Countries: Australia, United States

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug Discovery and Development | Countries: United States

Amazon BioTech - Strategic SWOT Analysis Review

Amazon BioTech - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Amazon BioTech (Amazon) is a pharmaceutical company. The company researches and develops natural drugs for the treatment of HIV disease based on immune-based therapies. It's AMZ0026 - Amazon Biotech's HIV drug phase I/II clinical studies have been approved by the FDA. Amazon's AMZ0026-H - AMZ0026's ...

Industries: Drug Discovery and Development | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.